Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Alex Kelly
 

Alex Kelly

 
Group VP - Global Communications, Investor Relations - Schering Plough Corp.
 
Alex Kelly Email :
Please login
 
Company Name : Schering Plough Corp.
 
Company Website : www.sch-plough.com
 
Company Address : 2000 Galloping Hill Rd.
, Kenilworth, NJ,
United States,
 
Alex Kelly Profile :
Group VP - Global Communications, Investor Relations - Schering Plough Corp.
 
Alex Kelly Biography :

Alex Kelly, R.Ph., is group vice president, Global Communications and Investor Relations, for Schering-Plough Corporation.

Kelly was named to his current position in October 2007 and is responsible on a global basis for Corporate External and Internal communications, Product Communications and Investor Relations. He is also responsible for communications related to the company's three core customer segments: Human Prescription Pharmaceuticals, Consumer Health Care and Animal Health. He joined Schering-Plough in April 2004 as vice president of Investor Relations.

Kelly has more than 18 years of experience in the pharmaceutical industry. Prior to joining Schering-Plough, Kelly was executive director of Investor Relations for Novartis Corporation. While at Novartis, he was based in Switzerland and focused on building relationships with European investors and analysts. Previously, Kelly was senior director of Investor Relations at Pharmacia Corporation. Prior to that assignment, he held a number of positions of increasing responsibility in Investor Relations and Sales at Pharmacia Corporation, Pharmacia & Upjohn and The Upjohn Company, where he began his career as a pharmaceutical sales representative.

Kelly holds a B.S. degree in pharmacy from Purdue University in Indiana.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

 
Alex Kelly Colleagues :
Name Title Email

Ellen Geisel

Sr. VP - Primary Care Customer Group, International Consumer Marketing Please login

Richard Bowles

Sr. VP - Global Quality Operations Please login

Brent Saunders

Sr. VP, Pres. - Consumer Health Care Please login

Raul Kohan

Sr. VP, Pres. - Animal Health Please login

Thomas Sabatino

Exec. VP, General Counsel Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.